Last reviewed · How we verify

NCT04319679

ESWT for UE Pain in Patients With Cervical Spinal Cord Injury

Terminated NA Last updated 14 April 2021
What this trial tests

NA trial testing Extracorporeal shockwave therapy in Spastic Tetraplegia in 4 participants. Terminated before completion.

Timeline
5 June 2020
Primary endpoint
5 April 2021
13 April 2021

Quick facts

Lead sponsorBundang CHA Hospital
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment4
Start date5 June 2020
Primary completion5 April 2021
Estimated completion13 April 2021
Sites1 location across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

Bundang CHA Hospital

Who can join

20 and older, any sex, with Spastic Tetraplegia or Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to investigate the efficacy and safety of extracorporeal shockwave therapy (ESWT) for upper extremity pain related to spasticity in patients with spinal cord injury.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Extracorporeal shockwave therapy

Trials testing the same drug.

Other Bundang CHA Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04319679.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing